Search
Displaying 11 - 20 of 24
Aug. 20, 2020, New York, NY — The National Kidney Foundation (NKF) in collaboration with the Academy of Nutrition and Dietetics released today the 2020 Kidney Disease Outcomes Quality Initiative (KDOQI) Clinical Practice Guideline on Nutrition in Chronic Kidney Disease that will guide health...
September 29, 2020—Moonstone Nutrition and the National Kidney Foundation are partnering to raise awareness about the prevalence of kidney stones and the importance of overall kidney health. Moonstone Nutrition and NKF will develop educational materials to teach consumers and healthcare professionals about...
FLAVIS, the kidney friendly food brand, and the National Kidney Foundation partner to promote medical nutrition therapy to help maintain residual kidney function among chronic kidney disease patients
New York, NY – April 8, 2019 – Dr. Schar USA’s (Lyndhurst, NJ) kidney friendly food brand, FLAVIS is teaming up with the National Kidney Foundation to...
Company recognized for developing the first new treatment for diabetic kidney disease (DKD) to be approved by the FDA in nearly two decades.
March 20, 2020, New York, NY —Janssen Pharmaceuticals Inc., part of the Janssen Pharmaceutical Companies of Johnson & Johnson has been selected to receive the 2020 Corporate Innovator Award from the National Kidney Foundation (NKF) as part of the annual ...
New York, NY–October 29, 2019 — Five young scientists have been awarded the National Kidney Foundation (NKF) Young Investigator Research Grants to advance knowledge about the treatment and prevention of kidney disease and kidney failure.
This year’s grants, will go to Vishnu Potluri, University of Pennsylvania, Philadelphia; Laith Al-Rabadi, University of Utah Hospital, Salt Lake City; Cristian Riella, Beth Israel Deaconess...
Dozens of experts, patients and policy makers expected to attend
June 27, 2019, New York, NY – Nearly 80 nephrologists, cardiologists, diabetologists, patients and policy makers will gather in Chicago this week to share information about a human protein called sodium-glucose contransporter-2 (SGLT2), its role in diabetic kidney disease and how a new drug...
Connie Rhee, MD, MSc, will be honored at NKF’s 2020 Spring Clinical Meetings
New York, NY – January 22, 2020 – Each year the National Kidney Foundation (NKF) considers the work of hundreds of specialists in the field of nephrology and selects among them those who most exemplify the relentless efforts of the NKF to enhance the lives of patients through action, education and accelerating change...
The National Kidney Foundation Statement about INVOKANA® (Canagliflozin)
New York, NY–Sept. 30, 2019— “The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that their drug INVOKANA® (Canagliflozin) has been approved by the U.S. Food and Drug Administration (FDA) to reduce the risk of end-stage kidney disease (ESKD) and cardiovascular events in patients with Type 2 diabetes and chronic kidney disease (...
National Kidney Foundation and The Monday Campaigns Team Up on Kidney Health
New York, NY—October 15, 2018—The National Kidney Foundation (NKF) is partnering with The Monday Campaigns' global public health initiatives, which include Meatless Monday, to encourage Americans to make healthier changes to their diets. Studies suggest that incorporating...
Patients share with FDA experience of living with this rare form of kidney disease
Editor’s update Nov. 15, 2019: The “Voice of the Patient” report from the Externally Led PFDD meeting on Alport syndrome has been posted by the ...